vs

Side-by-side financial comparison of EXELIXIS, INC. (EXEL) and Mid-America Apartment Communities (MAA). Click either name above to swap in a different company.

EXELIXIS, INC. is the larger business by last-quarter revenue ($598.7M vs $553.7M, roughly 1.1× Mid-America Apartment Communities). On growth, Mid-America Apartment Communities posted the faster year-over-year revenue change (438.7% vs 5.6%). Over the past eight quarters, EXELIXIS, INC.'s revenue compounded faster (18.7% CAGR vs 0.7%).

Exelixis, Inc. is a genomics-based drug discovery company located in Alameda, California, and the producer of Cometriq, a treatment approved by the U.S. Food and Drug Administration (FDA) for medullary thyroid cancer with clinical activity in several other types of metastatic cancer.

Mid-America Apartment Communities, Inc. (MAA) is a publicly traded real estate investment trust based in Memphis, Tennessee that invests in apartments in the Southeastern United States and the Southwestern United States.

EXEL vs MAA — Head-to-Head

Bigger by revenue
EXEL
EXEL
1.1× larger
EXEL
$598.7M
$553.7M
MAA
Growing faster (revenue YoY)
MAA
MAA
+433.1% gap
MAA
438.7%
5.6%
EXEL
Faster 2-yr revenue CAGR
EXEL
EXEL
Annualised
EXEL
18.7%
0.7%
MAA

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
EXEL
EXEL
MAA
MAA
Revenue
$598.7M
$553.7M
Net Profit
$244.5M
Gross Margin
95.6%
Operating Margin
39.3%
Net Margin
40.8%
Revenue YoY
5.6%
438.7%
Net Profit YoY
74.8%
EPS (diluted)
$0.89
$4.34

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EXEL
EXEL
MAA
MAA
Q1 26
$598.7M
$553.7M
Q4 25
$597.8M
$555.6M
Q3 25
$568.3M
$554.4M
Q2 25
$555.4M
$549.9M
Q1 25
$566.8M
$549.3M
Q4 24
$549.8M
Q3 24
$539.5M
$551.1M
Q2 24
$637.2M
$546.4M
Net Profit
EXEL
EXEL
MAA
MAA
Q1 26
$244.5M
Q4 25
$193.6M
$57.6M
Q3 25
$184.8M
$99.5M
Q2 25
$159.6M
$108.1M
Q1 25
$139.9M
$181.7M
Q4 24
$166.6M
Q3 24
$118.0M
$115.2M
Q2 24
$226.1M
$102.0M
Gross Margin
EXEL
EXEL
MAA
MAA
Q1 26
95.6%
Q4 25
96.9%
Q3 25
96.6%
Q2 25
96.5%
Q1 25
96.5%
Q4 24
Q3 24
96.8%
Q2 24
97.2%
Operating Margin
EXEL
EXEL
MAA
MAA
Q1 26
39.3%
Q4 25
39.6%
10.4%
Q3 25
37.6%
18.7%
Q2 25
33.6%
20.2%
Q1 25
28.8%
34.0%
Q4 24
31.3%
Q3 24
25.2%
21.5%
Q2 24
43.3%
19.3%
Net Margin
EXEL
EXEL
MAA
MAA
Q1 26
40.8%
Q4 25
32.4%
10.4%
Q3 25
32.5%
18.0%
Q2 25
28.7%
19.7%
Q1 25
24.7%
33.1%
Q4 24
30.3%
Q3 24
21.9%
20.9%
Q2 24
35.5%
18.7%
EPS (diluted)
EXEL
EXEL
MAA
MAA
Q1 26
$0.89
$4.34
Q4 25
$0.69
$0.48
Q3 25
$0.65
$0.84
Q2 25
$0.55
$0.92
Q1 25
$0.47
$1.54
Q4 24
$1.43
Q3 24
$0.40
$0.98
Q2 24
$0.77
$0.86

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EXEL
EXEL
MAA
MAA
Cash + ST InvestmentsLiquidity on hand
$1.1B
Total DebtLower is stronger
Stockholders' EquityBook value
$2.2B
Total Assets
$2.8B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EXEL
EXEL
MAA
MAA
Q1 26
$1.1B
Q4 25
$988.5M
$60.3M
Q3 25
$791.1M
$32.2M
Q2 25
$1.0B
$54.5M
Q1 25
$1.1B
$55.8M
Q4 24
$43.0M
Q3 24
$1.2B
$50.2M
Q2 24
$1.0B
$62.8M
Stockholders' Equity
EXEL
EXEL
MAA
MAA
Q1 26
$2.2B
Q4 25
$2.2B
$5.7B
Q3 25
$2.0B
$5.8B
Q2 25
$2.1B
$5.9B
Q1 25
$2.2B
$5.9B
Q4 24
$5.9B
Q3 24
$2.3B
$5.9B
Q2 24
$2.1B
$6.0B
Total Assets
EXEL
EXEL
MAA
MAA
Q1 26
$2.8B
Q4 25
$2.8B
$12.0B
Q3 25
$2.7B
$11.9B
Q2 25
$2.8B
$11.8B
Q1 25
$2.9B
$11.8B
Q4 24
$11.8B
Q3 24
$3.0B
$11.8B
Q2 24
$2.8B
$11.6B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EXEL
EXEL
MAA
MAA
Operating Cash FlowLast quarter
$333.5M
Free Cash FlowOCF − Capex
$332.4M
FCF MarginFCF / Revenue
55.5%
Capex IntensityCapex / Revenue
0.2%
Cash ConversionOCF / Net Profit
1.36×
TTM Free Cash FlowTrailing 4 quarters
$875.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EXEL
EXEL
MAA
MAA
Q1 26
$333.5M
Q4 25
$290.3M
$261.7M
Q3 25
$49.0M
$266.4M
Q2 25
$211.4M
$353.4M
Q1 25
$240.3M
$196.6M
Q4 24
$239.1M
Q3 24
$271.3M
$309.5M
Q2 24
$119.5M
$349.4M
Free Cash Flow
EXEL
EXEL
MAA
MAA
Q1 26
$332.4M
Q4 25
$288.8M
$158.6M
Q3 25
$46.2M
$170.8M
Q2 25
$208.5M
$264.5M
Q1 25
$236.3M
$124.0M
Q4 24
$152.6M
Q3 24
$263.1M
$215.5M
Q2 24
$113.0M
$259.7M
FCF Margin
EXEL
EXEL
MAA
MAA
Q1 26
55.5%
Q4 25
48.3%
28.5%
Q3 25
8.1%
30.8%
Q2 25
37.5%
48.1%
Q1 25
41.7%
22.6%
Q4 24
27.8%
Q3 24
48.8%
39.1%
Q2 24
17.7%
47.5%
Capex Intensity
EXEL
EXEL
MAA
MAA
Q1 26
0.2%
Q4 25
0.2%
18.6%
Q3 25
0.5%
17.2%
Q2 25
0.5%
16.2%
Q1 25
0.7%
13.2%
Q4 24
15.7%
Q3 24
1.5%
17.1%
Q2 24
1.0%
16.4%
Cash Conversion
EXEL
EXEL
MAA
MAA
Q1 26
1.36×
Q4 25
1.50×
4.55×
Q3 25
0.27×
2.68×
Q2 25
1.32×
3.27×
Q1 25
1.72×
1.08×
Q4 24
1.43×
Q3 24
2.30×
2.69×
Q2 24
0.53×
3.43×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EXEL
EXEL

Cabometyx$544.7M91%
Collaboration$52.1M9%
Collaborative Arrangementwith Takeda$5.9M1%
Cometriq$1.8M0%

MAA
MAA

Same Store Communities$517.0M93%
Non-Same Store Communities$22.1M4%
Lease-up/Development Communities$7.7M1%
Commercial Property/Land$7.0M1%

Related Comparisons